Whatsapp: +40723141550 Bucharest, Romania (Europe)
CERVUGID Ovules Treatment is indicated in cervico-vaginal inflammatory processes (vaginitis, cervicitis), in pelvic inflammatory congestions (pelviperitonitis, adnexitis, metritis, pelvic cellulitis, inflammatory processes accompanying benign or malignant tumor formations).
A special efficiency was also observed in the treatment of vaginal ulcerations of an inflammatory nature, which in over 90% of cases epithelize after only 2-3 treatments. Cervugid Ovules are indicated in the preoperative preparation of various genital diseases, a situation in which they ensure a favorable evolution, without infectious complications. They have also proven to be particularly useful for menopausal women who have local disorders (burns, discomfort, stress urinary incontinence, etc.).
The CERVUGID Formula is particularly effective, having very high concentrations of active substances, which are released immediately after application and covers all the causes that can cause cervico-vaginal infections and internal genital inflammation: microbial germs, mycoses, protozoa, as well as a group of inframicrobial agents - chlamydia, mycoplasmas and rickets.
In the case of CERVUGID, the success of the treatment consists in the fact that relapses no longer occur. In addition, an increase in local defense power is achieved, thus preventing infection withHPV (the human papilloma virus), proven and recognized as the etiological agent of cervical cancer. A very large percentage of young women up to 20-25 years old have this virus, which is transmitted through sexual contact. The virus lives in the cells of the cervical mucosa and causes precancerous morphological changes. The women in whom these changes were detected and who were treated with CERVUGID during the analysis no longer presented precancerous changes. It was a surprise for us too.
This drug is used to treat or prevent vaginal infections and cervical caused by micro-organisms.
Indications are:
Treatment of Human Papilloma Virus (HPV) high risk and low risk.
Treatment of vaginitis and cervicitis caused by aerobic and anaerobic bacteria (including Clostridium spp.), Gram-positive or Gram-negative
Treatment of vaginitis caused by Trichomonas vaginalis and cervicitis in combination with other micro-organisms;
Treatment of vaginal and cervicitis caused by Mycoplasma spp. Or Chlamydia spp. With other types of micro-organisms;
Treatment of vaginal fungal infections caused by Candida spp. With other types of micro-organisms;
Mixed vaginitis treatment products, the combination of bacteria, Trichomonas vaginalis, Candida spp and Mycoplasma spp., Or Chlamydia spp;
Vaginitis and cervicitis prophylaxis for patients undergoing treatment with systemic immunosuppressive chemotherapy or corticosteroids for patients undergoing radiotherapy;